Knowing the population’s immune status to guide public decision-making - EpiCOV
Knowing the population’s immune status to guide public decision-making
The aim of the EpiCoV project is to characterize the prevalence of the epidemic at the national and "département" scales, measure the effects of living conditions on exposure to the virus and, conversely, the effects of the epidemic on living conditions. The “Epidemiology and living conditions” survey or EpiCoV was launched by INSERM and DREES (the statistics office of the French Ministry of Health and Solidarity), with assistance from INSEE and Santé-Publique-France, to analyze the effects of the COVID-19 pandemic. The EpiCoV team includes epidemiologists, sociologists, demographers, and economists from INSERM, INED, the CNRS, and the Universities of Paris-Saclay and Paris-Dauphine.
The survey follows how the epidemic evolves by questioning the same respondents over several waves. The first was conducted partially on internet and partially by telephone from May 2 to June 2, 2020, thereby covering the end of the first general lockdown period, which began in March, and the first few weeks of reopening, which began on May 11. INSEE used the FIDELI (Demographic files on housing and individuals) database to draw a random sample of 135,000 people aged 15 or over on January 1, 2020, and living in ordinary?/typical? [le lecteur va-t-il savoir ce qu’est un “ménage ordinaire”?] household structures in metropolitan France, Martinique, Guadeloupe, and Reunion. The second survey section was conducted from late October to late November 2020.
This project is carried by Ariane Pailhé, senior Researcher at INED.